marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
BioMarin Pharmaceutical Cash Flow 2011-2024 | BMRN
Annual Cash Flow BioMarin Pharmaceutical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
159 M | 176 M | 305 M | 85.4 M | 48.3 M | 20.2 M | -8.76 M | -228 M | - | - | -59.6 M | 17.6 M | 18.4 M |
Depreciation & Amortization |
104 M | 102 M | 108 M | 105 M | 105 M | 95.7 M | 87.9 M | 96.9 M | 47.2 M | 45.9 M | 36 M | 45.3 M | 36.1 M |
Accounts Payables |
- | - | - | - | - | - | - | - | - | 32.8 M | 36.9 M | 24 M | 12.2 M |
Accounts Receivables |
634 M | 461 M | 373 M | 448 M | 377 M | 343 M | 261 M | 215 M | 165 M | 144 M | 118 M | 109 M | 105 M |
Total Inventories |
1.11 B | 894 M | 777 M | 699 M | 680 M | 531 M | 476 M | 355 M | 272 M | 199 M | 163 M | 129 M | 130 M |
All numbers in USD currency
Quarterly Cash Flow BioMarin Pharmaceutical
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 47 M | - | - | - | -73.9 M | - | 169 M | - | -45.4 M | - | 293 M | - | 114 M | - | 98.7 M | 12.5 M | -15.2 M | - | -9.08 M | -79.2 M | -54.9 M | - | -29.2 M | -76.4 M | -42.5 M | - | -23.4 M | -61.7 M | - | - | - | - | - | - | - | - | - | - | - | - | -26.9 M | - | - | - | -32 M | - | 5.62 M | -8.59 M | -7.17 M | - | 18.9 M | 10.1 M | -3.5 M |
Depreciation & Amortization |
10.9 M | 11.5 M | 27.4 M | - | 9.9 M | 9.4 M | 26.4 M | - | 8.7 M | 9.5 M | 27.3 M | - | 82.1 M | 11.8 M | 28 M | - | 77.8 M | 51.2 M | 26 M | - | 79.5 M | 48.8 M | 22.4 M | - | 71 M | 44.6 M | 23.6 M | - | 59.2 M | 38.5 M | 19.4 M | - | 76.8 M | 47.4 M | 18.7 M | - | 34.3 M | 22.3 M | 10.8 M | - | 39.9 M | 25.7 M | 12 M | - | 37.5 M | 24.2 M | 11.3 M | - | 33.4 M | 21.8 M | 10.6 M | - | 26.5 M | 17.1 M | 8.58 M |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.1 M | 23.6 M | 32.8 M | 37.7 M | 21.7 M | 32.8 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 24 M | 24 M | 24 M | 24 M | 12.2 M | 12.2 M | 12.2 M | 12.2 M |
Accounts Receivables |
778 M | 691 M | 637 M | 634 M | 572 M | 610 M | 598 M | 461 M | 420 M | - | 430 M | 373 M | 375 M | 424 M | 396 M | 448 M | 448 M | 448 M | 448 M | 377 M | 377 M | 377 M | 377 M | 343 M | 343 M | 343 M | 343 M | 261 M | 261 M | 261 M | 261 M | 215 M | 215 M | 215 M | 215 M | 165 M | 165 M | 165 M | 165 M | 144 M | 144 M | 144 M | 144 M | 118 M | 118 M | 118 M | 118 M | 109 M | 109 M | 109 M | 109 M | 105 M | 105 M | 105 M | 105 M |
Total Inventories |
1.18 B | 1.18 B | 1.14 B | 1.11 B | 1.03 B | 976 M | 919 M | 894 M | 839 M | - | 786 M | 777 M | 749 M | 711 M | 714 M | 699 M | 699 M | 699 M | 699 M | 680 M | 680 M | 680 M | 680 M | 531 M | 531 M | 531 M | 531 M | 476 M | 476 M | 476 M | 476 M | 355 M | 355 M | 355 M | 355 M | 272 M | 272 M | 272 M | 272 M | 199 M | 199 M | 199 M | 199 M | 163 M | 163 M | 163 M | 163 M | 129 M | 129 M | 129 M | 129 M | 130 M | 130 M | 130 M | 130 M |
All numbers in USD currency